Press Releases - Lifestyle Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam September 23, 2026
Press Releases - Lifestyle TENA Answers Women’s Most-Searched Pelvic Floor Questions For Healthy Aging Month September 23, 2026
Press Releases - Travel Xinhua Silk Road: Foreign influencers explore spectacular scenery of northeastern China in Heilongjiang September 23, 2026
Press Releases - Lifestyle ZEELOOL and Aimee Song Launch New Eyewear Collection With “Let’s Frame Your Vibe” September 23, 2026
Press Releases EIB acts to strengthen Europe’s power grids with €19 million in financing for Reactive Technologies September 23, 2026
Press Releases - Lifestyle The science that brought green back to China’s Loess Plateau awarded the 2026 Volvo Environment Prize September 23, 2026
Press Releases - Lifestyle Epson Introduces SureColor F370 and New Cotton Primer Solution to Help Creators and Small Businesses Personalize More Products with Dye-Sublimation September 23, 2026
Press Releases - Lifestyle Co-Creating Future Transit Value: CRRC Brings Three Full-Size Trains and End-to-End Solutions to InnoTrans 2026 September 23, 2026
Press Releases - Lifestyle The Appointment Ends and the Questions Begin. Bay Area Cancer Connections Answers Them on “All Access hosted by Andy Garcia” September 23, 2026
Press Releases Ctrl Alt Appoints Amanda Staveley as Board Director and Strategic Advisor September 23, 2026
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 8 months ago